Waters Corporation Instrument Systems — Revenue decreased by 13.1% to $376.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.0%, from $262.89M to $376.00M. Over 4 years (FY 2021 to FY 2025), Instrument Systems — Revenue shows relatively stable performance with a 0.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests strong demand for new laboratory infrastructure and capital equipment upgrades, while a decrease may signal market saturation, longer sales cycles, or reduced research and development spending by clients.
This metric represents the total revenue generated from the sale of analytical instrument systems, including liquid chro...
Comparable to capital equipment revenue segments in life sciences and analytical instrumentation peers, often tracked as a proxy for R&D investment trends in the broader scientific community.
wat_segment_instrument_systems_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $314.50M | $296.09M | $441.23M | $325.22M | $337.68M | $336.83M | $463.04M | $302.94M | $342.01M | $319.43M | $397.20M | $241.94M | $294.06M | $323.08M | $419.62M | $262.89M | $308.42M | $341.48M | $432.85M | $376.00M |
| QoQ Change | — | -5.9% | +49.0% | -26.3% | +3.8% | -0.3% | +37.5% | -34.6% | +12.9% | -6.6% | +24.3% | -39.1% | +21.5% | +9.9% | +29.9% | -37.3% | +17.3% | +10.7% | +26.8% | -13.1% |
| YoY Change | — | — | — | — | +7.4% | +13.8% | +4.9% | -6.9% | +1.3% | -5.2% | -14.2% | -20.1% | -14.0% | +1.1% | +5.6% | +8.7% | +4.9% | +5.7% | +3.2% | +43.0% |